Tumour volume response, initial cell kill and cellular repopulation in B16 melanoma treated with cyclophosphamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
about
Reversibility of apoptosis in cancer cells.Assessment of tumor cell repopulation after chemotherapy for advanced ovarian cancer: pilot study.The influence of P-glycoprotein expression and its inhibitors on the distribution of doxorubicin in breast tumors.Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11.Chemoradiotherapy: emerging treatment improvement strategies.Cell yield and cell survival following chemotherapy of the B16 melanoma.Influence of anaesthetics on tumour-cell kill and repopulation in B16 melanoma treated with melphalanResponse to chemotherapy of EMT6 spheroids as measured by growth delay and cell survival.Cell subpopulations dispersed from solid tumours and separated by centrifugal elutriation.Differential effect of hyperthermia and x-irradiation on regrowth rate and tumour-bed effect for a rat sarcoma.Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.Effect of misonidazole or metronidazole pretreatment on the response of the RIF-1 mouse sarcoma to melphalan, cyclophosphamide, chlorambucil and CCNU.Relation of growth delay to cure for experimental tumour systems conforming to Poisson cure statisticsResponse of two mouse tumours to hyperthermia with CCNU or melphalan.Experimental combination and single-agent chemotherapy in human lung-tumour xenograftsThe response to chemotherapy of a variety of human tumour xenograftsClonogenic assays in the B16 melanoma: response to cyclophosphamide.Accelerated regrowth of non-small-cell lung tumours after induction chemotherapy.Scheduling of paclitaxel and gefitinib to inhibit repopulation for optimal treatment of human cancer cells and xenografts that overexpress the epidermal growth factor receptor.Experimental chemotherapy studies: intercomparison of assays.Can dose-survival parameters be deduced from in situ assays?Effect of high-dose melphalan on marrow and intestinal epithelium in mice pretreated with cyclophosphamideRepopulation of gamma-irradiated Lewis lung carcinoma by malignant cells and host macrophage progenitors.Comparison of growth delay and cell survival as end-points of tumour response following treatment with combinations of cytotoxic agents.Role of vascular normalization in benefit from metronomic chemotherapy.Predictive chemosensitivity testing.Growth response of B16 melanoma to in vivo treatment with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) at the initial stage after tumor transplantation.
P2860
Q30485754-1DC331C6-F3C4-4E12-8A81-3B5D93396BF9Q30721358-42B7CEA8-BCB1-477B-B2F5-FD9D402962E8Q33508944-12FA2D5F-A249-44F3-992D-93336AC75C89Q33721749-7A0252CE-FB4B-46FD-A7CB-E2AF46DF5D3DQ35037705-E283553E-2552-490F-99F2-82E3361F5315Q36042667-7A4CA89B-AB50-4DB5-80A0-F2EEADA542C2Q36042770-2B52239A-84FE-464E-B860-02F6071A264CQ36044196-7A65F003-C41F-473F-A6DB-6D87F66E5EAEQ36045196-A88E726B-CDFB-488A-B8E7-BF39BC581BA8Q36045910-520EA22E-C482-4048-B193-A3C9719F486AQ36046032-2F089248-9422-429B-AF7D-481386FE89C3Q36046062-2DBE2445-2E3E-474A-98D9-4975DDF3DC4EQ36046214-D8B68513-7E98-425D-A713-5EA09DDB5073Q36046298-56975EC4-ADB6-4788-B190-6BFEA9C033DEQ36046646-03C49415-9864-4E78-A447-746EB9B4C5CCQ36047330-0469D720-EA33-47E4-8640-9EAFDF18B2A9Q36069144-E7A88663-A45E-4894-BD74-3ED17F276006Q36673537-3522F035-ECE0-447D-B3D0-070C5E32D47AQ39126147-7132D6FA-38F5-4B46-B9B1-B8A36478AAEFQ40292560-9FE0E8F8-DE1A-44D9-BD1A-CDFD36CE4B78Q40292573-DA372FC2-E167-46DA-8FE0-B842C3BFBBF5Q41461933-D72DD033-B2F4-44CD-809C-58EA8E2443E5Q41464100-E939AA7C-6885-4AA1-B474-DC73A3510026Q42264993-F1333DAF-1840-4834-9E32-C72F4113C2B0Q42318133-04CCF37C-4FAC-4F56-BEAA-C45E2A66544FQ42374199-A55CED0A-738E-48A0-B288-65A5B655B7C5Q42737717-F756336D-245E-47D5-827F-0FD53F40E22D
P2860
Tumour volume response, initial cell kill and cellular repopulation in B16 melanoma treated with cyclophosphamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
1977年论文
@zh
1977年论文
@zh-cn
name
Tumour volume response, initia ...... l)-3-cyclohexyl-1-nitrosourea.
@ast
Tumour volume response, initia ...... l)-3-cyclohexyl-1-nitrosourea.
@en
type
label
Tumour volume response, initia ...... l)-3-cyclohexyl-1-nitrosourea.
@ast
Tumour volume response, initia ...... l)-3-cyclohexyl-1-nitrosourea.
@en
prefLabel
Tumour volume response, initia ...... l)-3-cyclohexyl-1-nitrosourea.
@ast
Tumour volume response, initia ...... l)-3-cyclohexyl-1-nitrosourea.
@en
P2860
P356
P1476
Tumour volume response, initia ...... l)-3-cyclohexyl-1-nitrosourea.
@en
P2093
Peacock JH
Stephens TC
P2860
P2888
P304
P356
10.1038/BJC.1977.195
P407
P577
1977-09-01T00:00:00Z